{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2017:AGXGS7RWGYIZBNGPKC7V4XRZWF","short_pith_number":"pith:AGXGS7RW","canonical_record":{"source":{"id":"1711.00285","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2017-11-01T10:58:41Z","cross_cats_sorted":[],"title_canon_sha256":"098165a94aade82f4c5c01fee9458a00b993df103335bc61a822881a1fa88257","abstract_canon_sha256":"a124060539c051216cd3c65fb724eae17382b8dc0c312787f4bc4398e366db81"},"schema_version":"1.0"},"canonical_sha256":"01ae697e36361190b4cf50bf5e5e39b14717e6e2da34c6f89bcefefe0ca4a198","source":{"kind":"arxiv","id":"1711.00285","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1711.00285","created_at":"2026-05-18T00:31:34Z"},{"alias_kind":"arxiv_version","alias_value":"1711.00285v1","created_at":"2026-05-18T00:31:34Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1711.00285","created_at":"2026-05-18T00:31:34Z"},{"alias_kind":"pith_short_12","alias_value":"AGXGS7RWGYIZ","created_at":"2026-05-18T12:31:05Z"},{"alias_kind":"pith_short_16","alias_value":"AGXGS7RWGYIZBNGP","created_at":"2026-05-18T12:31:05Z"},{"alias_kind":"pith_short_8","alias_value":"AGXGS7RW","created_at":"2026-05-18T12:31:05Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2017:AGXGS7RWGYIZBNGPKC7V4XRZWF","target":"record","payload":{"canonical_record":{"source":{"id":"1711.00285","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2017-11-01T10:58:41Z","cross_cats_sorted":[],"title_canon_sha256":"098165a94aade82f4c5c01fee9458a00b993df103335bc61a822881a1fa88257","abstract_canon_sha256":"a124060539c051216cd3c65fb724eae17382b8dc0c312787f4bc4398e366db81"},"schema_version":"1.0"},"canonical_sha256":"01ae697e36361190b4cf50bf5e5e39b14717e6e2da34c6f89bcefefe0ca4a198","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:31:34.552910Z","signature_b64":"N8AyNPe7ikRjCX018QMfCKoQgwY6AZXVEOGdh0qy4sZqGtDMoWLC85TbD6kqxn8uzkTa0DpFVT8kkEKmdibIDA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"01ae697e36361190b4cf50bf5e5e39b14717e6e2da34c6f89bcefefe0ca4a198","last_reissued_at":"2026-05-18T00:31:34.552442Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:31:34.552442Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1711.00285","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:31:34Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"NUWoh2JkTIKha6XZoGv70sR/Zj0TOgNV57cfgaFgS5K6TxurGfeYdJhu6WfbwiRXEuqBsDm6H+wfHtLfK6/ECA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-31T23:30:20.620598Z"},"content_sha256":"d22940917aa0d2538be95082823e2eb64bec438876cefb8d30b5363bf1743d3a","schema_version":"1.0","event_id":"sha256:d22940917aa0d2538be95082823e2eb64bec438876cefb8d30b5363bf1743d3a"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2017:AGXGS7RWGYIZBNGPKC7V4XRZWF","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Personalized Schedules for Surveillance of Low Risk Prostate Cancer Patients","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Anirudh Tomer, Daan Nieboer, Dimitris Rizopoulos, Ewout W. Steyerberg, Monique J. Roobol","submitted_at":"2017-11-01T10:58:41Z","abstract_excerpt":"Low risk prostate cancer patients enrolled in active surveillance (AS) programs commonly undergo biopsies on a frequent basis for examination of cancer progression. AS programs employ a fixed schedule of biopsies for all patients. Such fixed and frequent schedules, may schedule unnecessary biopsies for the patients. Since biopsies have an associated risk of complications, patients do not always comply with the schedule, which increases the risk of delayed detection of cancer progression. Motivated by the world's largest AS program, Prostate Cancer Research International Active Surveillance (PR"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1711.00285","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:31:34Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"UzPHU5CEaIizMiR6DyWSs4bg9iDzi87YjQFiMV8No5MUfUq0NRjW+IZywh1wvZRDq1EK1gFerMT2AgZL1Gf5Aw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-31T23:30:20.621366Z"},"content_sha256":"17489f64353fcc9121c13edfef571aa03c84b01a57a6f5c2d4fa7a4426cbc17e","schema_version":"1.0","event_id":"sha256:17489f64353fcc9121c13edfef571aa03c84b01a57a6f5c2d4fa7a4426cbc17e"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF/bundle.json","state_url":"https://pith.science/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-31T23:30:20Z","links":{"resolver":"https://pith.science/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF","bundle":"https://pith.science/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF/bundle.json","state":"https://pith.science/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF/state.json","well_known_bundle":"https://pith.science/.well-known/pith/AGXGS7RWGYIZBNGPKC7V4XRZWF/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2017:AGXGS7RWGYIZBNGPKC7V4XRZWF","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"a124060539c051216cd3c65fb724eae17382b8dc0c312787f4bc4398e366db81","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2017-11-01T10:58:41Z","title_canon_sha256":"098165a94aade82f4c5c01fee9458a00b993df103335bc61a822881a1fa88257"},"schema_version":"1.0","source":{"id":"1711.00285","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1711.00285","created_at":"2026-05-18T00:31:34Z"},{"alias_kind":"arxiv_version","alias_value":"1711.00285v1","created_at":"2026-05-18T00:31:34Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1711.00285","created_at":"2026-05-18T00:31:34Z"},{"alias_kind":"pith_short_12","alias_value":"AGXGS7RWGYIZ","created_at":"2026-05-18T12:31:05Z"},{"alias_kind":"pith_short_16","alias_value":"AGXGS7RWGYIZBNGP","created_at":"2026-05-18T12:31:05Z"},{"alias_kind":"pith_short_8","alias_value":"AGXGS7RW","created_at":"2026-05-18T12:31:05Z"}],"graph_snapshots":[{"event_id":"sha256:17489f64353fcc9121c13edfef571aa03c84b01a57a6f5c2d4fa7a4426cbc17e","target":"graph","created_at":"2026-05-18T00:31:34Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Low risk prostate cancer patients enrolled in active surveillance (AS) programs commonly undergo biopsies on a frequent basis for examination of cancer progression. AS programs employ a fixed schedule of biopsies for all patients. Such fixed and frequent schedules, may schedule unnecessary biopsies for the patients. Since biopsies have an associated risk of complications, patients do not always comply with the schedule, which increases the risk of delayed detection of cancer progression. Motivated by the world's largest AS program, Prostate Cancer Research International Active Surveillance (PR","authors_text":"Anirudh Tomer, Daan Nieboer, Dimitris Rizopoulos, Ewout W. Steyerberg, Monique J. Roobol","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2017-11-01T10:58:41Z","title":"Personalized Schedules for Surveillance of Low Risk Prostate Cancer Patients"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1711.00285","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:d22940917aa0d2538be95082823e2eb64bec438876cefb8d30b5363bf1743d3a","target":"record","created_at":"2026-05-18T00:31:34Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"a124060539c051216cd3c65fb724eae17382b8dc0c312787f4bc4398e366db81","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2017-11-01T10:58:41Z","title_canon_sha256":"098165a94aade82f4c5c01fee9458a00b993df103335bc61a822881a1fa88257"},"schema_version":"1.0","source":{"id":"1711.00285","kind":"arxiv","version":1}},"canonical_sha256":"01ae697e36361190b4cf50bf5e5e39b14717e6e2da34c6f89bcefefe0ca4a198","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"01ae697e36361190b4cf50bf5e5e39b14717e6e2da34c6f89bcefefe0ca4a198","first_computed_at":"2026-05-18T00:31:34.552442Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:31:34.552442Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"N8AyNPe7ikRjCX018QMfCKoQgwY6AZXVEOGdh0qy4sZqGtDMoWLC85TbD6kqxn8uzkTa0DpFVT8kkEKmdibIDA==","signature_status":"signed_v1","signed_at":"2026-05-18T00:31:34.552910Z","signed_message":"canonical_sha256_bytes"},"source_id":"1711.00285","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:d22940917aa0d2538be95082823e2eb64bec438876cefb8d30b5363bf1743d3a","sha256:17489f64353fcc9121c13edfef571aa03c84b01a57a6f5c2d4fa7a4426cbc17e"],"state_sha256":"b4055617db61d3bc45e4c057d0c540035e166b8d0f359816559f5da85eee1759"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"DS3G5GD6Ok/KrEMUgQyl8Jr7gPugBZm+/dybrnQdddW813zsu4QUf15smnrlbWOiBrmSuyEXRcK7mtCalG+JAA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-31T23:30:20.625463Z","bundle_sha256":"9075684dfc66985455bd1d19bca1bc9c8a0ccdcf4b674cbd7483e6cbc0476d4b"}}